Certolizumab Can Also Be Effective in Monotherapy for the Treatment of Rheumatoid Arthritis Patients
Pedro Santos-Moreno,1 Susan Martinez,2 Linda Ibatá,2 Laura Villarreal,1 Manuel Rivero,3 Adriana Rojas-Villarraga4 1Rheumatology, Biomab IPS, Bogotá, DC, Colombia; 2Epidemiology, Biomab IPS, Bogotá, DC, Colombia; 3Pharmacy, Biomab IPS, Bogotá, DC, Colombia; 4Rheumatology, Research División, Fundación...
Enregistré dans:
Auteurs principaux: | Santos-Moreno P, Martinez S, Ibatá L, Villarreal L, Rivero M, Rojas-Villarraga A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4fe734f522e14ae7a2031af7e86d303a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
par: Acosta-Felquer ML, et autres
Publié: (2016) -
Functional implications of B lymphocytes in the development of rheumatoid arthritis
par: Juan-Manuel Anaya, et autres
Publié: (2006) -
Rheumatoid arthritis hand lesions assessed with outcome measures in rheumatoid arthritis clinical trials-rheumatoid arthritis magnetic resonance imaging score – proposing an extended rheumatoid arthritis magnetic resonance imaging score
par: M. del Carmen Larios-Forte, et autres
Publié: (2021) -
Knee alterations in rheumatoid arthritis: Comparison of US and MRI
par: Xiao Lu, et autres
Publié: (2021) -
Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept
par: Al-Ani N, et autres
Publié: (2021)